Prof Vernon Sondak speaks with ecancer at the EADO 2018 congress in Barcelona about managing the uncertainty of Spitz Nevi melanoma.
Prof Sondak explains that there is a small number of atypical spitz tumours where it is difficult to determine whether it is truly benign or if it is truly cancerous, leading to confusion and uncertainty for patients and doctors.
He details that there are ways to manage the uncertainty and that, if it comes to it, they can treat the worst case scenario, which isn't always as bad as feared.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
